Vetivex 3 (Sodium Chloride 0.9% w/v and Glucose 5% w/v Infusion BP)

Country: United Kingdom

Language: English

Source: VMD (Veterinary Medicines Directorate)

Active ingredient:

Glucose, Sodium Chloride

Available from:

Dechra Limited

ATC code:

QB05BB02

INN (International Name):

Glucose, Sodium Chloride

Pharmaceutical form:

Solution for infusion

Prescription type:

POM-V - Prescription Only Medicine – Veterinarian

Therapeutic group:

Cats, Cattle, Dogs, Horses

Therapeutic area:

Replacement Agent

Authorization status:

Authorized

Authorization date:

1998-12-10

Summary of Product characteristics

Revised: October 2015
AN: 00685/2015
Page 1 of 4
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
Vetivex 3 (Sodium Chloride 0.9% w/v and Glucose 5% w/v Infusion BP )
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Active substances:
Sodium chloride
0.9 % w/v
Glucose monohydrate
5.5 % w/v
(equivalent to anhydrous glucose 5.0 % w/v)
Approximate ionic content in millimoles per litre:
Sodium
150 mmol/L
Chloride
150 mmol/L
For the full list of excipients, see section 6.1
Each one litre provides approximately 200 kcal.
3.
PHARMACEUTICAL FORM
Solution for infusion.
Clear, colourless solution.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cattle, calves, horses, dogs and cats.
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
For the treatment of dehydration in cattle, calves, horses, dogs and
cats. It
may be used to correct hypovolaemia resulting from shock or
gastrointestinal
disease. It may be administered to meet normal fluid and electrolyte
requirements when fluids cannot be given orally. The glucose is not a
significant calorie source but can provide transient improvement of
hypoglycaemia.
4.3
CONTRAINDICATIONS
None.
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
None.
Revised: October 2015
AN: 00685/2015
Page 2 of 4
4.5
SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
Infusion rates should not exceed 10ml/kg/hour to minimise the risk of
glycosuria and osmotic diuresis.
Administration of this product to diabetic animals must be conducted
with extreme caution.
Sodium overload may occur in animals with cardiac or renal
impairment. It should be noted that sodium excretion may be impaired
post-surgery/trauma.
Special precautions to be taken by the person administering the
veterinary
medicinal product to animals
Not applicable.
4.6
ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
There is a risk of thrombosis with intravenous infusion.
4.7
USE DURING PREGNANCY AND LACTATION OR LAY
Use under veterinary supervision.
4.8
INTERACTION WITH OTHER VETERINARY MEDICINAL PRODUCTS AND OTHE